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In the few decades, there has been exponentional growth in the field of herbal medicines. Most of the 
traditional systems of medicine are effective due to lack of standardization. So there is a need to develop a 
standardization technique. Standardization of herbal formulation is essential in order to assess the quality, 
purity, safety and efficacy of the drug. There is increasing awareness and general acceptability of the use 
herbal drugs in today’s medical practice. The world population depends on herbal medicines and product for 
healthy living. This rise in the use of herbal product has also given rise to various forms of adulteration of the 
products, which leading to consumers’ and manufacturers’ disappointment and in some instances fatal 
consequences. The challenge is innumerable and enormous, to fulfill the need of global herbal market. The 
standardization of this formulations like the organoleptic characters, physical properties, the various physic-
chemical properties such as moisture content, ash values, extractive values need to be carried out along with 
Thin layer chromatography and heavy metal content study should also carried out to ascertain the quality, 
purity and safety of this herbal formulation. 
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INTRODUCTION 
The use of herbs as medicine is the oldest form of 
healthcare known to humanity and has been used in all 
cultures throughout history1. It is very important that, a 
system of standardization is established for every plant 
medicines in the market; because, the scope for 
variation in different batches of medicine is enormous. 
The phytochemical content of plant materials may vary 
based on places and time of collection, which finally 
influence therapeutic efficiency. Different 
environmental factors and cultivation techniques also 
play important role for production of particular 
medicinal plants. This indicate the need of suitable 
quality control test for the entire preparation to ensure 
quality of the product2,3,4. As commercialization of the 
herbal medicines is going on, assurance of safety, 
quality and efficacy become an important issue. The 
herbal raw materials are prone to a lot of variation due 
to several factors, the important one is, being the 
identity of the plants and seasonal variation (which has 
a bearing on the time of collection), the ecotypic, 
genotypic and chemotypic variations, drying and 
storage conditions and the presence of xenobiotics. 
Standardization, as defined by American Herbal 
Product association: ―Standardization refers to the 
body of information and control necessary to product 
material of reasonable consistency. This achieved 
through minimizing the inherent variation of natural 
product composition through quality assurance 
practices applied to agricultural and manufacturing 
processes.  
Methods of standardization should take into 
consideration all aspects that contribute to the quality 
of the herbal drugs, namely correct identity of the 
sample, organoleptic evaluation, pharmacognostic 
evaluation, volatile matter, quantitative evaluation (ash 
values, extractive values), phytochemical evaluation, 
test for the presence of xenobiotics, microbial load 
testing, toxicity testing, and biological activity. 
Phytochemical profile is of special significance since it 
has a direct bearing on the activity of the herbal drugs. 
The fingerprint profiles serve as guideline to the 
phytochemical profiling of the drug in ensuring the 
quality, while quantification of the marker compound/s 
would serve as an additional parameter in assessing the 
quality of the sample5,6. Herbal medicines are generally 
regarded as safe based on their long-standing use in 
various cultures. However, there are case reports of 
serious adverse events after administration of herbal 
products. In a lot of cases, the toxicity has been traced 
due to contaminants and adulteration. However, some 
of the plants used in herbal medicines can also be 
highly toxic. As a whole, herbal medicines can have a 
risk of adverse effects and drug–drug and/or drug–food 
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interactions if not properly assessed. Assessment of the 
safety of herbal products, therefore, is the first priority 
in herbal research.  
There are various approaches to the evaluation of 
safety of herbal medicines. The toxic effects of herbal 
preparation may be attributed mainly to the following: 
• Inherent toxicity of plant constituents and ingredients 
• Manufacturing malpractice and contamination 
Evaluation of the toxic effects of plant constituents of 
herbal formulation requires detailed phytochemical and 
pharmacological studies. It is, however, safe to assume 
that, based on human experiences in various cultures, 
the use of toxic plant ingredients has already been 
largely eliminated and recent reports of toxicity could 
largely be due to misidentification and overdosing of 
certain constituents7. 
World Health Organization (WHO) has defined herbal 
medicines as finished, labeled medicinal products that 
contain active ingredients, aerial or underground parts 
of the plant or other plant materials or combinations. 
WHO has set specific guidelines for the assessment of 
the safety, efficacy, and quality of herbal medicines. 
WHO estimates that approx 81% of the world 
populations presently use herbal medicines for primary 
health care8. WHO stresses the importance of the 
qualitative and quantitative methods for characterizing 
the samples, quantification of the biomarkers and/ or 
chemical markers and the fingerprint profiles. If a 
principle active component is known, it is most logical 
to quantitate these compounds. Where active 
ingredients contributing to therapeutic efficacy are 
known botanical preparations should be standardized to 
these compounds. Where the active ingredients are not 
yet known a marker substance which should be specific 
for the botanical could be chosen for analytical 
purpose5,9.   
 
HERBAL MEDICINE 
An herb is a plant or part of a plant valued for its 
medicinal, aromatic or savory qualities. Herbs can be 
viewed as biosynthetic chemical laboratories, 
producing a number of chemical compounds. Herbal 
remedies or medicines consist of portions of plants or 
unpurified plant extracts containing several 
constituents, which often work together synergistically. 
Herbal medicine or herbalism is the use of herbs or 
herbal products for their therapeutic or medicinal 
value. They may come from any part of the plant but 
are most commonly made from leaves, roots, bark 
seeds, and flowers. They are eaten, swallowed, drunk, 
inhaled, or applied topically to the skin.  Herbal 
products often contain a variety of naturally-occurring 
biochemical’s from plants, many of which contribute to 
the plant’s medicinal benefits. Chemicals known to 
have medicinal benefits are referred to as ―active 
ingredients‖ or ―active principles‖ and their presence 
depends on a number of factors including the plant 
species, the time and season of harvest, the type of soil, 
the way the herb is prepared, etc.1  
Herbs include crude plant materials, such as leaves, 
flowers, fruit, seeds, stems, wood, bark, roots, 
rhizomes or other plant parts, which may be entire, 
fragmented or powdered.  
Herbal materials include, in addition to herbs, fresh 
juices, gums, fixed oils, essential oils, resins and dry 
powders of herbs. In some countries, these materials 
may be processed by various local procedures, such as 
steaming, roasting or stir-baking with honey, alcoholic 
beverages or other materials. 
Herbal preparations are the basis for finished herbal 
products and may include comminuted or powdered 
herbal materials, or extracts, tinctures and fatty oils of 
herbal materials. They are produced by extraction, 
fractionation, purification, concentration, or other 
physical or biological processes. They also include 
preparations made by steeping or heating herbal 
materials in alcoholic beverages and/or honey, or in 
other materials. 
Finished herbal products consist of herbal 
preparations made from one or more herbs. If more 
than one herb is used, the term ―mixture herbal 
product‖ can also be used. Finished herbal products 
and mixture herbal products may contain excipients in 
addition to the active ingredients. However, finished 
products or mixture herbal products to which 
chemically defined active substances have been added, 
including synthetic compounds and/or isolated 
Journal of Applied Pharmaceutical Research ISSN No. 2348 – 0335 www.japtronline.com 
 
October – December 2013 Volume 1                                         Issue 1  16 
 
constituents from herbal materials, are not considered 
to be herbal5,10 .  
 
ADVANTAGES OF HERBAL MEDICINE 
1. They have large amount of use. 
2. They have better patient tolerance as well as 
acceptance. 
3. The medicinal plants have renewable source of 
cheaper medicines. 
4. Improvements in the quality, efficacy and safety of 
herbal medicines with the development of science 
and technology. 
5. Prolong and apparently uneventful use of herbal 
medicines may offer testimony of their safety and 
efficacy. 
6. They are cheap in cost. 
7. They are not harmful. 
8. They are more effective than any synthetic drug. 
9. Throughout the world herbal medicines have 
provided many of the most potent medicines to the 
vast arsenal of drugs available to modern medical 
science, both in crude form as well as a pure 
chemical upon which modern medicines are 
constructed.11,12   
 
SOURCES OF TOXIC CHEMICALS AND 
CONTAMINATION IN HERBAL PRODUCT 
The practices of most ethnic herbal medicines include 
the use of crude or raw herbs that are collected from 
the wild or from cultivated fields and their prepared or 
ready-made (formulated mixture of herbal or other 
natural materials) products. Toxic contaminants may 
come from: 
 Environments and conditions that the 
medicinal plants are grown or collected. 
 The conditions under which they are dried and 
processed. 
 The storage conditions and conditions during 
transport. 
 The manufacturing processes when the ready-
made medicinal products are produced. 
WHO has also paid serious attention on mycotoxin 
contamination in herbal drugs, considering it as a 
global problem. Detection of mycotoxins  is certainly a 
matter of great concern in stored drugs of important 
medicinal plants.  
Table I List of drug containing mycotoxins  
DRUG  
Concentration of 
mycotoxins (mg/g) 
Roots/ rhizomes of Asparagus racemosus 0.16 
Atropa belladonna 0.27 
Withania somnifera 0.68 
Plumbago zelanica 1.13 
Terminalia chebula 1.19 
Seeds of Macuna puriens 1.16 
Such herbal drugs containing mycotoxins above the 
tolerance limit fixed by WHO for human consumption, 
will be certainly rejected in the global market.13-15 
 
PROBLEMS SPECIFIC TO THE QUALITY OF 
HERBAL DRUGS
 
 Herbal drugs are mixtures of many constituents 
 The active principle(s) is (are) hardly known 
 Selective analytical methods may not yet exist 
 Reference compounds may not be available 
commercially 
 Chemical variability of plant material 
 Natural variation/biodiversity 
 Chemovarieties (eg, Thyme) and Chemocultivars 
(eg, Chamomile) 
 Influence of harvest, drying, and storage 
conditions 
 Influence of processing (different extracts: polarity 
of solvent, mode of extraction, instability of 
constituents)16  
 
NEED OF STANDARDIZATION 
The quality control of herbal crude drug & formulation 
is important in justifying their acceptability in modern 
system of medicines. Standardization of synthetic 
drugs offers no problem with very well defined 
parameters of analysis. It is not uncommon to have as 
many as five or more different herbal ingredients in 
one single formulation. The batch to batch variation 
starts from the collection of the raw materials itself in 
absence of any reference standard for identification. 
WHO has emphasized the need to ensure quality 
control of medicinal plants products by using modern 
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techniques and by applying suitable standards and 
parameters. Standardized products and services are 
valuable User confidence builders' being perceived as 
 Safe & Healthy 
 Secure 
 High Quality 
 Flexible 
Standardization brings important benefits to business 
including a solid foundation upon which new 
technologies are developed and an opportunity to share 
and enhance existing practices. Standardization also 
plays a pivotal role in assisting Governments, 
Administrations, Regulators and the legal profession as 
legislation, regulation and policy initiatives are all 
supported by standardization.17  
 
 
PROTOCOLS FOR STANDARDIZATION OF HERBAL EXTRACTS 
Table II Parameters for standardization of herbs 
Parameter Specification 
Authentication Identification of plant species with Latin binomial name Steps involves taxonomic, 
macroscopic and microscopic studies. Stage of collection, part of the plant, regional 
status, botanical identity such as phytomorphology, microscopical and histological 
analysis, taxonomical identity etc. 
Physical parameters Physical tests include organoleptic evaluation, viscosity, moisture content, pH, 
disintegration time, hardness, ash value etc. 
Chromatographic and 
spectroscopic evaluation 
Sophisticated modern techniques of standardization such as UV, FTIR, HPTLC, HPLC, 
GCMS,LCMS, NMR 
Microbiological 
parameters 
Microbial contamination can be measured according to validated or pharmacopeia 
methodology. Example: E. coli and molds, total enteriobacterial, aflatoxin 
Pesticide residue analysis Standard limits of pesticides as per WHO and FAO 
 (Food and Agricultural Organization. Example: DDT, BHC, toxaphene and aldrin 
Heavy metal analysis Toxic metals such as Mercury(Hg), Lead (Pb), Cadmium (Cd), Arsenic (As), Copper 
(Cu), Iron (Fe), Zinc (Zn) as per specifications7,18 .  
 
GUIDELINES FOR HERBAL DRUG 
STANDARDIZATION (WHO guidelines)  
The subject of herbal drug standardization is massively 
wide and deep. The guidelines set by WHO can be 
summarized as follows 
 Reference to the identity of the drug. Botanical 
evaluation- sensory characters, foreign organic 
matter, microscopical, histological, histochemical 
evaluation, quantitative measurements etc. 
 Reference to the physicochemical character of the 
drug. Physical and chemical identity, 
chromatographic fingerprints, ash values, 
extractive values, moisture content, volatile oil and 
alkaloidal assays, quantitative estimation protocols 
etc. 
 Reference to the pharmacological parameters, 
biological activity profiles, bitterness values, 
haemolytic index, astringency, swelling factor, 
foaming index etc. 
  Toxicity details- pesticide residues, heavy metals, 
microbial contamination like total viable count, 
pathogens like E.coli, Salmonalla, P.aeroginosa, 
S. aureus, Enterobacteria etc. 
  Microbial contamination. 
  Radioactive contamination.19  
DOCUMENTED OR REGULATORY 
APPROACHES FOR HERBAL MEDICINES  
Herbal medicines were first included in the WHO 
International Conference on Drug Regulatory 
Authorities in 1986. In 1991, WHO prepared draft 
guidelines for assessment of herbal medicines, which 
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were adopted by the 6th International Conference on 
Drug Regulatory Authorities (ICDRA). This includes 
basic criteria for quality, safety  and efficacy of herbal 
medicines. These guidelines provide valuable 
assistance to national regulatory authorities, scientific 
organizations and manufacturers to undertake 
assessment of documentation of submissions. 
Following the recommendations of the 6th ICDRA in 
1991, WHO continued to develop pharmaceutical 
monographs on herbal medicines on the basis of 
guidelines for the assessment of herbal medicines: Part 
I: Botanical Characteristics, Major Active Constituents, 
and Quality Control (QC); and Part II: Summaries of 
Clinical Applications, Pharmacology, Precautions, and 
Adverse Reactions. 
The purpose of the WHO monographs was to 
 Provide scientific information on safety, efficacy, 
and quality control of medicinal plants, 
 Facilitate proper use of herbal medicines. 
Documentation of herbal medicine should involve 
documentation on the cultivation, harvesting, and 
technologies involved, including: plantation 
development and processing methods; the prior 
validation of products used in herbal medicine; 
documentation of the properties of synthetic products 
identical with or related to the active constituent(s) of 
the medicine; the chemistry of herbs believed to be 
responsible for the activity; the results of any clinical 
trials carried out on the product and aspects of 
marketing and trading; and legal issues including IPR. 
This is an unenviable task as only a fraction of the 
hundreds of thousands of plant species has been fully 
investigated in the laboratory. 
In United States, herbal products can only be marketed 
as food supplements. Specific health claims need U.S. 
Food and Drug Administration (FDA) approval. The 
European Guidelines for the Assessment of Herbal 
Medicines state that a substance’s historical use is valid 
to document safety and efficacy, in the absence of 
scientific evidence to the contrary. 
Two features of the European approach are as follows: 
 Costs are less, it takes less time to approve herbal 
medicines as safe and effective, and one can apply 
the ―doctrine of reasonable certainty‖, which does 
not compromise safety. 
 No inherent prejudice exists against complex plant 
substances; they are considered safe and 
effective7,20.   
 
TRADITIONAL APPROACHES FOR 
STANDARDIZATION OF HERBAL MEDICINES 
Methods for quality control of herbal medicines 
involve sensory inspection (macroscopic and 
microscopic examinations). Macroscopic identity of 
botanical materials is based on parameters like shape, 
size, colour, texture, surface characteristics, fracture 
characteristics, odour, taste and such organoleptic 
properties that are compared to a standard reference 
material. Microscopy involves comparative 
microscopic inspection of broken as well as powdered, 
crude, botanical materials and analytical inspection 
using instrumental techniques such as thin layer 
chromatography, HPLC, GC.MS, LC.MS, near infrared 
(NIR), and spectrophotometry etc. Analytical HPLC 
whereas both the degree of solute purity as well as the 
amount of compound that can be produced per unit 
time i.e. throughput or recovery in preparative HPLC 15, 
22-23. 
 
HERBAL MEDICINE REGULATION IN EU, US AND INDIA 
Table III Regulation for Herbal Medicine 
Country Regulatory authority Description Regulation/Act 
EU European Medicines Agency 
(EMEA): The 
Committee on Herbal Medicinal 
Products 
(HMPC) 
Establishment of HMPC and 
regulation of herbal medicine 
 
Registration Procedure for 
traditional herbal medicinal 
Directive 2004/24/EC 
(Traditional Herbal Medicinal 
Products Directive) and 
Regulation (EC) No 726/2004. 
Articles 16a to 16i of Directive 
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products 2001/83/EC 
US USFDA: Center for Drug 
Evaluation and 
Research (CDER) 
 
 
 
 
Center for Biologics Evaluation 
and Research (CBER) 
Botanical drug definition 
Regulation of herbal product 
 
Procedure for marketing of 
Botanical 
drug as OTC drug 
 
Regulation of Allergenic 
extracts and vaccines that 
contain botanical ingredients 
201(g)(1)(B),Federal Food, Drug, 
and Cosmetic Act, Dietary 
Supplement Health and Education 
Act of 1994 
(DSHEA) 
21 CFR 10.20, 10.30, 312, 314, 
321, 324, 330, 331–358 
Section 351 of the Public Health 
Service Act (42 U.S.C. 262) 
India Department of. Ayurveda, Yoga 
& Naturopathy, Unani, Siddha 
and Homoeopathy (AYUSH) 
Production and marketing of 
ASU drugs 
 
GMP for ASU drugs 
Drugs & Cosmetics Act, 1940 
Drugs & Cosmetics Rules, 1945 
Schedule T, Drugs & Cosmetics 
Act, 1940 .21  
 
CHROMATOGRAPHIC METHODS  
Chemical and chromatographic techniques may be 
used to aid in identification of an herbal material or 
extract. Chromatographic technique such as HPLC, 
TLC, GC and capillary electrophoresis and 
spectroscopic methods such as IR, NMR, and UV may 
also be used for fingerprinting. DNA fingerprinting has 
been widely used in many species, e.g. DNA 
fingerprinting of Panax species and their adulterants. 
Marker compounds may be used to help identify herbal 
materials, set specifications for raw materials, 
standardize botanical preparations during all aspects of 
manufacturing processes and obtain stability profiles. 
Central Council for Research in Ayurveda and Siddha 
gave list of phytoconstituents which is used for 
analysis of crude drugs or herbal formulations 
containing these crude drugs22, 24.  
  
TLC  
TLC is a simple, low-cost, versatile and specific 
method for the identification of herbal medicines. The 
unique feature of picture-like image of TLC supplies 
an intuitive visible profiling.24 Nowadays HPTLC is a 
routine analytical technique. It has been well reported 
that several samples can be run simultaneously by use 
of a smaller quantity of mobile phase than in HPLC 
It has also been reported that mobile phases of pH 8 
and above can be used for HPTLC. Another advantage 
of HPTLC is the repeated detection (scanning) of the 
chromatogram with the same or different conditions. 
Consequently, HPTLC has been investigated for 
simultaneous assay of several components in a multi-
component formulation. With this technique, 
authentication of various species of plant possible, as 
well as the evaluation of stability and consistency of 
their preparations from different manufactures22,  25.  
 
HPLC 
Preparative and analytical HPLC are widely used in 
pharmaceutical industry for isolating and purification 
of herbal compounds. There are basically two types of 
preparative HPLC: low pressure HPLC (typically 
under 5 bar) and high pressure HPLC (pressure >20 
bar). The important parameters to be considered are 
resolution, sensitivity and fast analysis time19. HPLC 
has been employed to analyze several components in a 
medicinal preparation composed of several crude drugs 
35,36,37. Among the analytical methods for 
standardization of Indian herbal medicines HPLC is the 
most popular one, due to its versatility, precision and 
relatively low cost, which represents a progress in 
comparison of the one or two marker quantitative 
approach. One of the main advantages of HPLC is that 
many detectors can be coupled with it, such as UV, 
DAD, ELSD, FLD, RID, MS, and NMR, etc., which 
supplies much more possibilities for detecting different 
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constituent types. In recent years, coulometric 
electrode array detection (HPLCCEAD) and charged 
aerosol detection (CAD) have been also introduced to 
the analysis of herbal formulations22, 26. 
 
GC AND HYPHENATED TECHNIQUES 
GC and GC-MS are unanimously accepted methods for 
the analysis of volatile constituents of herbal 
medicines, due to their sensitivity, stability and high 
efficiency. Especially, the hyphenation with MS 
provides reliable information for the qualitative 
analysis of the complex constituents. In recent years so 
many workers developed GC or GC hyphenated with 
MS for the analysis of phytoconstituents such as 
thymol, eucalyptol, menthol, camphor from honey and 
bees wax (Gas chromatography with flame ionisation 
detection), estragole, safrole and eugenol methyl ether 
in food products (Gas- chromatograph directly 
interfaced with GCQ plus mass spectrometer) , eugenol 
(GC with flame ionization detector)  and sugars (Gas 
chromatograph interfaced with mass selective 
detector).27 
 
CONCLUSION  
The field of the herbal drugs and formulations is very 
vast and there is still lot to explore on the subject of 
standardization of these. So, while developing an 
herbal drug formulation it is must to have all the 
related knowledge of that particular drug including all 
its organoleptic characters to 
phytoconstituents to pharmacological action to its 
standardization in respect to various parameters via 
various techniques. Monographs as compiled in the 
standard books like Indian Pharmacopoeia, Ayurvedic 
Pharmacopoeia of India, Wealth of India and 
Ayurvedic formulary, provide all the details for the 
various tests to be performed in order to determine the 
conformity of the crude or formulated herbal drug with 
the standards lay. It is also important to study the 
influence of the variousfactors like effect of the 
environment, climate, growth conditions and condition 
of the storage on the potency of a crude drug or the 
formulation prepared using it as a whole or as extract 
or the constituent isolated. It is also important to 
standardize, not only the main drug constituent but also 
the other excipients and additives incorporated. 
Every day a new chemical entity is being identified and 
isolated from the existed or newly identified crude 
drugs, so a need of the stringent regulation has arise to 
determine the conformity of these new chemicals to 
assess their physicochemical, pharmacological, clinical 
activities along with their safety and efficacy. 
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